Polymorphism of DNA repair genes in breast cancer. 2019

Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
Laboratory of Cancer Genetics, Department of Clinical Pathology, Polish Mothers' Memorial Hospital-Research Institute, Lodz, Poland.

OBJECTIVE The aim of the study was to determine the relationship between single nucleotide polymorphisms (SNPs) of DNA repair genes and modulation of the risk of breast cancer. The following SNPs were analysed: XRCC1-Arg399Gln (rs25487), hMSH2-Gly322Asp (rs4987188), XRCC2-Arg188His (rs3218536), XPD- Lys751Gln (rs13181), RAD51--4719A/T (rs2619679) and RAD51--4601A/G (rs5030789). METHODS The study included n = 600 patients: 300 with breast cancer and 300 healthy controls. The HRM (High-Resolution Melter) technique was applied for polymorphism analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele. RESULTS Statistically significant correlations were identified between four single nucleotide polymorphisms and the breast cancer risk: XRCC1-Arg399Gln, hMSH2-Gly322Asp, XPD- Lys751Gln and RAD51--4719A/T. Allele XRCC1-Gln (OR 6.37; 95% CI 4.86-8.35, p < .0001), hMSH2-Asp (OR 4.41; 95% CI 3.43-5.67, p < .0001), XPD -Gln (OR 2.56; 95% CI 2.02-3.25, p < .0001) and RAD51-T genes (OR 1.44; 95% CI 1.15-1.80, p = 0.002) strongly correlated with breast carcinoma. No relationship was observed between the studied polymorphisms and the cancer progression grade according to Scarf-Bloom-Richardson classification. CONCLUSIONS The results implies that polymorphisms of DNA repair genes may be associated with breast cancer occurrence.

UI MeSH Term Description Entries

Related Publications

Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
January 2008, Polish journal of pathology : official journal of the Polish Society of Pathologists,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
March 2015, Experimental oncology,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
November 1999, Science (New York, N.Y.),
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
October 2019, Pathology oncology research : POR,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
January 2019, Pathology oncology research : POR,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
January 2017, Pathology oncology research : POR,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
January 2013, International journal of cancer,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
August 2009, Experimental and molecular pathology,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
June 2017, The Journal of pathology,
Beata Smolarz, and Magdalena M Michalska, and Dariusz Samulak, and Hanna Romanowicz, and Luiza Wójcik
February 2012, Molecular biology reports,
Copied contents to your clipboard!